On June 12, Praxis Precision Medicines rose 5.81% in regular trading, trading at $262.38/share, with Turnover of $9.893 million.
Within the Biotechnology sector where Praxis Precision Medicines belongs, individual stocks showed mixed performance. Among individual stocks, Nuvalent down 0.17%, AbbVie up 0.67%, Amgen down 0.18%, Gilead Sciences down 0.71%, Insmed down 0.33%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)